Application of Fragment-Based Screening & Fragment-Based Drug Discovery to the Development of Cancer Therapeutics
Time: 9:30 am
day: Conference Day One
Details:
- Unveiling the potential of Fragment-Based Screening (FBS) in identifying hits on challenging targets
- Leveraging NMR and SPR in understanding molecular interactions and real-time detection of molecular binding events
- Best practices to overcome the weak interactions of fragment-based screening
